HomeCompareJCRRF vs VICI

JCRRF vs VICI: Dividend Comparison 2026

JCRRF yields 3.22% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JCRRF wins by $589.34M in total portfolio value· pulled ahead in Year 2
10 years
JCRRF
JCRRF
● Live price
3.22%
Share price
$4.17
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$590.33M
Annual income
$557,098,169.44
Full JCRRF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — JCRRF vs VICI

📍 JCRRF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJCRRFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JCRRF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JCRRF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JCRRF
Annual income on $10K today (after 15% tax)
$273.77/yr
After 10yr DRIP, annual income (after tax)
$473,533,444.02/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, JCRRF beats the other by $473,003,671.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JCRRF + VICI for your $10,000?

JCRRF: 50%VICI: 50%
100% VICI50/50100% JCRRF
Portfolio after 10yr
$295.66M
Annual income
$278,860,715.38/yr
Blended yield
94.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

JCRRF
No analyst data
Altman Z
1.4
Piotroski
4/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JCRRF buys
0
VICI buys
0
No recent congressional trades found for JCRRF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJCRRFVICI
Forward yield3.22%6.57%
Annual dividend / share$0.13$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%44.3%
Portfolio after 10y$590.33M$988.8K
Annual income after 10y$557,098,169.44$623,261.32
Total dividends collected$587.89M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: JCRRF vs VICI ($10,000, DRIP)

YearJCRRF PortfolioJCRRF Income/yrVICI PortfolioVICI Income/yrGap
1$11,344$644.17$11,368$948.43$24.00VICI
2← crossover$13,504$1,365.91$13,339$1,493.16+$165.00JCRRF
3$17,489$3,039.22$16,326$2,426.21+$1.2KJCRRF
4$26,070$7,356.96$21,123$4,112.15+$4.9KJCRRF
5$48,393$20,498.67$29,379$7,368.23+$19.0KJCRRF
6$122,906$71,124.57$44,804$14,191.64+$78.1KJCRRF
7$469,147$337,637.75$76,658$29,972.12+$392.5KJCRRF
8$2,910,974$2,408,986.96$150,894$71,015.81+$2.76MJCRRF
9$31,053,709$27,938,966.99$350,814$193,582.47+$30.70MJCRRF
10$590,325,638$557,098,169.44$988,809$623,261.32+$589.34MJCRRF

JCRRF vs VICI: Complete Analysis 2026

JCRRFStock

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Full JCRRF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this JCRRF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JCRRF vs SCHDJCRRF vs JEPIJCRRF vs OJCRRF vs KOJCRRF vs MAINJCRRF vs NNNJCRRF vs EPRTJCRRF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.